Evaluating Genetic Modifiers of Cutaneous Neurofibromas in Adults With Neurofibromatosis Type 1
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,046
- 试验地点
- 2
- 主要终点
- Determination of genetic variants associated with clinical presentations of NF1.
研究概览
简要总结
The main goal of this protocol is to develop a well-phenotyped genetic biobank to identify genetic variants associated with the heterogeneous clinical presentations of Neurofibromatosis Type 1 (NF1). This will allow for improve understanding of NF1 pathogenesis and more personalized disease management. The investigators will conduct a GWAS analysis to identify common genetic risk variants associated with the development of cutaneous neurofibromas.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 40 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 40 or older.
- •NF type 1 diagnosed using clinical criteria.
- •At least one neurofibroma present at time of enrollment.
- •Patient able to read and understand consent form (or equivalent translation) and able to give consent.
- •Patient able and willing to complete all study procedures.
排除标准
- 未提供
结局指标
主要结局
Determination of genetic variants associated with clinical presentations of NF1.
时间窗: Day 1
GWAS analysis will identify common genetic risk variants associated with the development of cutaneous neurofibromas in patients with NF1.
次要结局
未报告次要终点
研究者
Kavita Sarin
Assistant Professor of Medicine
Stanford University
